3i Infotech Receives Order for Platform Modernization from Medical Supplies Delivery Services Company
3i Infotech Limited announced on April 2, 2026, that its wholly-owned step-down subsidiary, 3i Infotech Inc., USA, has secured an order from a leading medical supplies delivery services company. The order, received on April 1, 2026, involves the modernization and re-engineering of the client's platforms.The engagement focuses on a comprehensive transformation into a scalable, cloud-native digital commerce ecosystem integrated with ERP through a secure middleware layer. The solution incorporates a microservices-based architecture, AI-enabled search and chatbot capabilities, middleware-driven system integration, and database modernization to improve user experience, operational efficiency, and real-time business visibility.
The total value of the order is approximately ₹1.63 crores, equivalent to $175,000. The project is expected to be executed over a period of 7 months.
Order Details
| Particulars | Details |
|---|---|
| Entity Awarding Order | A leading medical supplies delivery services company |
| Order Description | Modernization and re-engineering of its platforms |
| Order Origin | International |
| Nature of Order | Transformation into intelligent and scalable digital platform with AI & analytics, integrated with ERP |
| Execution Timeframe | 7 Months |
| Order Value | $175,000 |
| Promoter/Group Interest | NA |
| Related Party Transaction | No |
The company is voluntarily disclosing this information as the order value is below the materiality threshold limits.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.